These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 9003047

  • 1. Regulation of delta-opioid receptor mRNA levels by receptor-mediated and direct activation of the adenylyl cyclase-protein kinase A pathway.
    Buzas B, Rosenberger J, Cox BM.
    J Neurochem; 1997 Feb; 68(2):610-5. PubMed ID: 9003047
    [Abstract] [Full Text] [Related]

  • 2. Modulation by calcium/calmodulin-dependent protein kinase II of functional response of delta opioid receptor in neuroblastoma x glioma hybrid (NG108-15) cells.
    Fan GH, Zhang WB, Yao CP, Pei G.
    Neuropharmacology; 1997 Feb; 36(11-12):1763-9. PubMed ID: 9517449
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regulation of adenylyl cyclase, ERK1/2, and CREB by Gz following acute and chronic activation of the delta-opioid receptor.
    Tso PH, Yung LY, Wong YH.
    J Neurochem; 2000 Apr; 74(4):1685-93. PubMed ID: 10737627
    [Abstract] [Full Text] [Related]

  • 5. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR, Fleming LM, Selley DE, McNutt RW, Chang KJ.
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [Abstract] [Full Text] [Related]

  • 6. Opioid receptor and calcium channel regulation of adenylyl cyclase, modulated by GM1, in NG108-15 cells: competitive interactions.
    Wu G, Lu ZH, Alfinito P, Ledeen RW.
    Neurochem Res; 1997 Oct; 22(10):1281-9. PubMed ID: 9342733
    [Abstract] [Full Text] [Related]

  • 7. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY, Bergsbaken C.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [Abstract] [Full Text] [Related]

  • 8. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY, Loh HH.
    Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
    [Abstract] [Full Text] [Related]

  • 9. Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain.
    Childers SR, Fleming L, Konkoy C, Marckel D, Pacheco M, Sexton T, Ward S.
    Ann N Y Acad Sci; 1992 Jun 28; 654():33-51. PubMed ID: 1321574
    [Abstract] [Full Text] [Related]

  • 10. Differential regulation by butyrate and dibutyryl cyclic AMP of delta-opioid, alpha 2-adrenergic, and muscarinic cholinergic receptors in NCB-20 cells.
    Zhu XZ, Chuang DM.
    J Neurochem; 1988 Jan 28; 50(1):17-26. PubMed ID: 2826684
    [Abstract] [Full Text] [Related]

  • 11. Altered adenylyl cyclase responsiveness subsequent to point mutations of Asp 128 in the third transmembrane domain of the delta-opioid receptor.
    Cavalli A, Babey AM, Loh HH.
    Neuroscience; 1999 Jan 28; 93(3):1025-31. PubMed ID: 10473267
    [Abstract] [Full Text] [Related]

  • 12. Cyclic AMP accumulation alters calmodulin localization in SK-N-SH human neuroblastoma cells.
    Mangels LA, Gnegy ME.
    Brain Res Mol Brain Res; 1992 Jan 28; 12(1-3):103-10. PubMed ID: 1347631
    [Abstract] [Full Text] [Related]

  • 13. Effects of C-terminal truncation of the recombinant delta-opioid receptor on phospholipase C and adenylyl cyclase coupling.
    Hirst RA, Smart D, Devi LA, Lambert DG.
    J Neurochem; 1998 Jun 28; 70(6):2273-8. PubMed ID: 9603191
    [Abstract] [Full Text] [Related]

  • 14. Chronic activation of inhibitory delta-opioid receptors cross-regulates the stimulatory adenylate cyclase-coupled prostaglandin E1 receptor system in neuroblastoma x glioma (NG108-15) hybrid cells.
    Ammer H, Schulz R.
    J Neurochem; 1995 Jun 28; 64(6):2449-57. PubMed ID: 7760024
    [Abstract] [Full Text] [Related]

  • 15. Orphanin FQ/nociceptin and mu-opioid receptor mRNA levels in human SH-SY5Y neuroblastoma cells: effects of activating the cAMP-PKA signal transduction pathway.
    Wallington CL, Peters DM, Gelb CR, Peterfreund RA.
    Brain Res; 2002 Jul 19; 944(1-2):73-81. PubMed ID: 12106667
    [Abstract] [Full Text] [Related]

  • 16. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
    Narita M, Mizoguchi H, Kampine JP, Tseng LF.
    Br J Pharmacol; 1996 Aug 19; 118(7):1829-35. PubMed ID: 8842450
    [Abstract] [Full Text] [Related]

  • 17. Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells.
    Johnston CA, Beazely MA, Vancura AF, Wang JK, Watts VJ.
    J Neurochem; 2002 Sep 19; 82(5):1087-96. PubMed ID: 12358756
    [Abstract] [Full Text] [Related]

  • 18. Determination of delta-opioid in NG108-15 cells.
    Ho BY, Holmes BB, Zhao J, Fujimoto J.
    Eur J Pharmacol; 1997 Jan 14; 319(1):109-14. PubMed ID: 9030905
    [Abstract] [Full Text] [Related]

  • 19. Suppression of phospholipase C blocks Gi-mediated inhibition of adenylyl cyclase activity.
    Fan GH, Zhou TH, Zhang WB, Pei G.
    Eur J Pharmacol; 1998 Jan 12; 341(2-3):317-22. PubMed ID: 9543254
    [Abstract] [Full Text] [Related]

  • 20. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
    Merkouris M, Dragatsis I, Megaritis G, Konidakis G, Zioudrou C, Milligan G, Georgoussi Z.
    Mol Pharmacol; 1996 Oct 12; 50(4):985-93. PubMed ID: 8863845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.